The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine‐depleted rats and MPTP‐treated monkeys
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Abnormally increased subthalamic nucleus output to the internal pallidal segment and the reticular part of the substantia nigra plays a critical pathophysiological role in the development of parkinsonism. Because synaptic transmission of subthalamic output is glutamatergic and mediated, in part, by the α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionate (AMPA)subtype of glutamate receptor, AMPA receptor antagonists may posses antiparkinsonian properties. We report that in monoamine‐depleted rats, 2,3‐dihydroxy‐6‐nitro‐7‐sulfamoyl‐benzo(f)quinoxaline (NBQX) (Novo‐Nordisk, Copenhagen, Denmark)—a selective antagonist of the AMPA subtype of glutamate receptor—suppressed muscular rigidity but had no effect on akinesia. NBQX microinjected into the subthalamic nucleus, internal pallidal segment, and reticular part of the substantia nigra, but not into the laterodorsal neostriatum of the rats, stimulated locomotor activity and reduced muscular rigidity. In aged Rhesus monkeys with bilateral 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydrophyridine‐induced parkinsonism intramuscular NBQX produced clinically apparent improvement in akinesia, tremor, posture, and gross motor skills. NBQX also potentiated the antiparkinsonian effects of L‐3,4‐dihydroxyphenylalanine in both rats and monkeys. Blockade of excitatory synaptic transmission by AMPA receptor antagonists may provide a new therapeutic strategy for Parkinson's disease (PD).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Morris, R. G. M., Anderson, E., Lynch, G. S., & Baudry, M. (1986) · Nature · doi:10.1038/319774a0 · Cited by 3,640
Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,614
Reversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus
Bergman, H., Wichmann, T., & DeLong, M. R. (1990) · Science · doi:10.1126/science.2402638 · Cited by 1,907
Pathological Changes Induced in Cerebrocortical Neurons by Phencyclidine and Related Drugs
Olney, J. W., Labruyere, J., & Price, M. T. (1989) · Science · doi:10.1126/science.2660263 · Cited by 1,237
2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a Neuroprotectant for Cerebral Ischemia
Sheardown, M. J., Nielsen, E. Ø., Hansen, A. J., Jacobsen, P., & Honoré, T. (1990) · Science · doi:10.1126/science.2154034 · Cited by 1,138
Self-citationMitchell, I. J., Clarke, C. E., Boyce, S., Robertson, R. G., Peggs, D., Sambrook, M. A., & Crossman, A. R. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90120-6 · Cited by 460
The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice
Carlsson, M., & Carlsson, A. (1989) · Journal of Neural Transmission · doi:10.1007/bf01258633 · Cited by 423
Miller, W. C., & DeLong, M. R. (1987) · Advances in Behavioral Biology · doi:10.1007/978-1-4684-5347-8_29 · Cited by 418
Robledo, P., & Féger, J. (1990) · Brain Research · doi:10.1016/0006-8993(90)90952-8 · Cited by 347
Bankiewicz, K. S., Oldfield, E. H., Chiueh, C. C., Doppman, J. L., Jacobowitz, D. M., & Kopin, I. J. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90431-5 · Cited by 308
Koek, W., Woods, J. H., & Winger, G. D. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24082-4 · Cited by 305
NMDA antagonists potentiate antiparkinsonian actions of L‐dopa in monoamine‐depleted rats
Klockgether, T., & Turski, L. (1990) · Annals of Neurology · doi:10.1002/ana.410280411 · Cited by 284
Self-citationAnticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats
Schmidt, W. J., & Bubser, M. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90007-5 · Cited by 165
EFFERENT MUSCLE INNERVATION AND RIGIDITY.
Steg, G. (1964) · PubMed · Cited by 151
Stereotaxis in Parkinson Syndrome
Hassler, R., Mundinger, F., & Riechert, T. (1979) · doi:10.1007/978-3-642-66521-9 · Cited by 133
Excitotoxicity of l-DOPA and 6-OH-DOPA: Implications for Parkinson's and Huntington's diseases
Olney, J. W., Zorumski, C. F., Stewart, G. R., Price, M. T., Wang, G., & Labruyere, J. (1990) · Experimental Neurology · doi:10.1016/0014-4886(90)90134-e · Cited by 128
Graham, W. C., Robertson, R. G., Sambrook, M. A., & Crossman, A. R. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90376-3 · Cited by 126
Kurlan, R., Kim, M. H., & Gash, D. M. (1991) · Movement Disorders · doi:10.1002/mds.870060205 · Cited by 120
Self-citationAlbin, R. L., Aldridge, J. W., Young, A. B., & Gilman, S. (1989) · Brain Research · doi:10.1016/0006-8993(89)90103-0 · Cited by 107
Rouzaire-Dubois, B., & Scarnati, E. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90133-3 · Cited by 94
Efferent muscle innervation and rigidity
Steg, G. (1964) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 87
Cited by
The Role of Excitotoxicity in Neurodegenerative Disease
Doble, A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00042-4 · Cited by 723
The subthalamic nucleus in the context of movement disorders
Hamani, C. (2004) · Brain · doi:10.1093/brain/awh029 · Cited by 585
Functional changes of the basal ganglia circuitry in Parkinson's disease
Blandini, F., Nappi, G., Tassorelli, C., & Martignoni, E. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00067-2 · Cited by 582
Gerlach, M., & Riederer, P. (1996) · Journal of Neural Transmission · doi:10.1007/bf01291788 · Cited by 498
Oxidative stress: Free radical production in neural degeneration
Götz, M. E., Künig, G., Riederer, P., & Youdim, M. B. H. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90055-8 · Cited by 482
Metadata
- Authors
- Klockgether, T., Turski, L., Honoré, T., Zhang, Z., Gash, D. M., Kurlan, R., & Greenamyre, J. T.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1991-11
- Volume
- 30
- Issue
- 5
- Pages
- 717-723
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1985415750
- Cited by
- 258
- References
- 22
- FWCI
- 26.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.